South Africa Reports Beta Variant (B.1.351)

South African scientists report detection of B.1.351 (later named Beta), a variant with mutations in the spike protein's receptor-binding domain that partially reduce vaccine effectiveness. Countries quickly impose travel bans on South Africa. Preliminary data shows AstraZeneca vaccine has only ~10% efficacy against mild-moderate Beta disease.